This platform is protected by over 600 patents and patent applications worldwide within the for a Phase 1/2a clinical trial of AST-OPC1 for the treatment of cervical spinal cord injury and is currently awaiting clearance from the for that trial.
http://ift.tt/1viFidc
http://ift.tt/1viFidc
No comments:
Post a Comment